Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival (Q40249082)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 November 2015
edit
Language Label Description Also known as
English
Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival
scientific article published on 26 November 2015

    Statements

    Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit